Discover how much money can be saved in your clinical trial!

Screen Shot 2018 06 27 at 11.15.03 PM

No Specific Characteristics Of A Duplicate Subject And A Research Subject Database Is Required

Without a “tool” such as the Verified Clinical Trials (VCT) global research subjects database registry, detecting duplicate subjects and protocol violations based upon prior study history or prior study drug (IP) exposure is impossible. VCT proactively detects these issues at the time of screening before costly screening procedures occur. The protections continue the entire duration …

Read more

Screen Shot 2019 05 14 at 8.39.59 PM

Protect Your Clinical Trials Against Duplicate Subjects and Professional Research Subjects

If you protect your computers against malware and viruses, why not protect your clinical trials from duplicate subjects that cause data quality and safety issues as well as failed clinical trials?  Verified Clinical Trials (VCT) is the leading global research subject database to prevent duplicate subjects in clinical trials  also known as professional research subjects. …

Read more

Screen Shot 2019 05 02 at 10.37.54 AM

Strategies to Combat Research Participant Dishonesty/Deception, Non-adherence, and Professional Subjects Using Verified Clinical Trials

Verified Clinical Trials (VCT) will be attending ASCP and will host a panel session: Bad Behavior in Clinical Trials: Strategies to Combat Research Participant Dishonesty/Deception, Non-adherence, and Professional Research Subjects. Verified Clinical Trials prevents duplicate subjects in clinical trials. The largest research subject database registry for CNS clinical trials and all other therapeutic areas #duplicatesubjects …

Read more

Screen Shot 2019 04 30 at 4.03.56 PM

Verified Clinical Trials (VCT) will be exhibiting again at the EUFEMED meeting in France May 15-17. VCT is the global research subject database registry utilized by phase 1- phase 4 clinical trials across the globe. VCT prevents over enrollment or duplicate subjects as well as many other key protocol violations to promote safety and data …

Read more

Characteristics Of Professional Research Subjects and Duplicate Subjects In CNS and Other Clinical Trials Prevented By Verified Clinical Trials

Professional research subjects or duplicate subjects in clinical trials cause safety concerns and poor quality data.  The Verified Clinical Trials global research subject database registry is a tool to detect duplicate subjects and prevents many protocol violations proactively at the time of screening.  What we have learned from experience and analytical data review over the …

Read more

Screen Shot 2019 04 23 at 4.01.09 PM

Research Sites Cooperate To Prevent Duplicate Subjects in CNS Clinical Trials By Using The Verified Clinical Trials Research Subject Registry

Duplicate subjects exist in most clinical trials to varying degrees.  CNS clinical trials are especially  prone to duplicate subject or over enrollment.  The issue exists from phase 1 healthy volunteer studies to multiple phase 2/3 clinical trials across many therapeutic indications.  Use of global research subject database registry such as Verified Clinical Trials will help …

Read more

Screen Shot 2019 04 05 at 3.24.31 PM

Preventing Duplicate Subjects In European Clinical Trials: Average Travel Distance

Verified Clinical Trials (VCT) has been well adopted in many research sites and CROs in several European countries.  Data again proves that research volunteers will travel significant distances to dual enroll in multiple clinical trials contemporaneously. There is a similar experience in the United States whereby duplicate subjects in clinical trials will travel thousands of …

Read more

Screen Shot 2018 05 10 at 10.06.19 PM

CNS Clinical Trials Are Prone To Duplicate Subjects and Duplicate Enrollment

CNS clinical trials, especially psychiatry clinical trials are prone to having duplicate subjects in clinical trials.  In studies that rely upon subjective end points, there exists the ability to provide false information in an effort to gain entry in to the study.  Of course, these occurrences result in failed trials due to elevated placebo rates or issues with safety if the volunteer does in fact take the investigational product (IP) from multiple sites.

Use of the Verified Clinical Trials (VCT) global research subject registry has been quite effective at stopping these issues at the time of screening. The protections continue throughout the entire study.  The Verified Clinical Trials network is expansive and covers multiple countries worldwide.  Nearly every phase 1 unit across the United States and now in Europe and elsewhere.  VCT protects many therapeutic indications but is especially focused on duplicate subjects in CNS clinical trials and duplicate subjects in psychiatry clinical trials.

The data is rather impressive with as preventable protocol violations including duplicate or dual enrollment in clinical trials ranging higher than 10% in some instances.  The National Institute of Health (NIH) uses VCT exclusively.

Screen Shot 2018 03 27 at 8.51.00 PM

Duplicate Subjects In Clinical Trials Prevented By Verified Clinical Trials

Duplicate subjects in clinical trials has attracted the attention of many clinical trial managers and study leads.  To prevent duplicate subjects or professional research subjects, many sponsors have added the use of Verified Clinical Trials (VCT) as a mandatory step during the screening process.  VCT verifies a research subject’s study history at the time of …

Read more